Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Equity earnings (loss) in AmerisourceBergen

Impairment of goodwill

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Walgreens

Duane Reade is a subsidiary of Walgreens Boots Alliance, is a chain of pharmacy and convenience stores, primarily located in New York City, known for its high volume small store layouts in densely populated Manhattan locations.

Duane Reade

Boots UK is a pharmacy chain in the United Kingdom, Ireland, Norway, Thailand and other territories. Boots became a subsidiary of the new company, Walgreens Boots Alliance, on 31 December 2014.

Boots UK

Alliance Healthcare was formerly Alliance UniChem, wholesales, distributes, and retails pharmaceutical, surgical, medical, and healthcare products throughout Europe. The company supplies more than 110,000 pharmacies, doctors, health centres and hospitals from over 288 distribution centres in 11 countries. The company is a wholly owned subsidiary of Walgreens Boots Alliance, which was formed by the merger of Walgreens with its former parent Alliance Boots in 2014. Alliance Boots had itself been formed in 2006 by the merger of Boots Group and Alliance UniChem on 31 July 2006. Alliance UniChem was rebranded Alliance Healthcare in 2009.

Alliance Healthcare

Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Walgreens reports Q1 earnings decline, eyes growth opportunities ahead

Walgreens faces challenges from COVID impacts and investments but is on track to achieve full-year guidance.
Strategic acquisitions and scaling U.S. Healthcare present opportunities for growth and profitability.
Despite first-half declines, the company anticipates improvements in margins and performance in the second half.
Efforts to optimize cash flow and investments position Walgreens for future growth and success.

Walgreens reports 4.5% sales growth in Q2 2023 earnings

Walgreens remains cautiously optimistic about managing potential changes in health plans and anticipates a strong second half of the year. The company is targeting debt reduction and small tuck-on acquisitions in healthcare as capital allocation priorities.

Walgreens (WBA) reports mixed Q3 performance, focuses on profitability

Walgreens (WBA) Q3 2023 earnings call highlights mixed performance with a focus on profitability enhancement.
Strategic partnerships, cost management programs, and capital allocation priorities support long-term value creation.
Challenges in margin pressures, script growth, and operational issues require immediate actions for profitability.
Opportunities lie in unlocking profitability, market developments, and demand for risk-based health care services.

Walgreens appoints new CEO to drive cost savings and script growth opportunities

Walgreens is strategically positioning itself for operational efficiency and cost savings in fiscal year 2024. The company's new CEO, Tim Wentworth, is expected to drive healthcare expertise and cost-effective outcomes. Despite challenges like lower contributions and segment declines, Walgreens is leveraging opportunities for script growth and financial improvement.

Walgreens Q1 Earnings: Navigating Challenges, Focused on Value Creation

Walgreens is navigating challenges in the pharmacy sector while focusing on strategic initiatives to drive value creation and sustainable growth. The company's emphasis on partnerships, cost-saving actions, and a shift towards value-based reimbursement models positions them for future success in the evolving healthcare landscape.

Walgreens reports solid Q2 results, focuses on growth strategies

Walgreens navigates retail challenges with strong operational performance. Focus on cost discipline, portfolio optimization, and cash flow improvement. Strategic decisions to drive growth and unlock value in healthcare areas.

Walgreens Q3 Earnings Miss Expectations Amid Challenges

Walgreens' Q3 2024 earnings call highlighted a challenging quarter with missed expectations, driven by pressures in the retail pharmacy sector and adverse market conditions. CEO Tim Wentworth emphasized ongoing strategic reviews and cost management initiatives as key to navigating these challenges. The company remains committed to transforming its business model to better serve customers and improve operational efficiency.

Walgreens (WBA) reports Q4 earnings, focuses on growth strategies

Walgreens (WBA) focused on financial stability, cost efficiency, and strategic growth initiatives in Q4 2024 earnings call.
The company aims to address challenges like disruptions, inflation, and underperforming stores while leveraging strengths in cash flow and cost-cutting.
Opportunities in store optimization, digital enhancement, and asset monetization are key areas for future growth.
Overall, Walgreens is navigating challenges, leveraging strengths, and pursuing opportunities to enhance financial performance and resilience.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Walgreens is the latest drugstore giant to promise its customers access to Covid-19 vaccines once available.

Walgreens: When Covid-19 Vaccines Are Available You Can ‘Count On Us'

CVS Health

GoodRx Holdings

Rite Aid

A few years ago, Amazon was supposed to disrupt the grocery industry. That didn't happen.

1 Big Reason Why Pharmacy Investors Shouldn't Fear Amazon

CF Industries Holdings

Equity Residential

Energy Transfer LP Unit

Federal Realty Investment Trust

Kennedy-Wilson Holdings

Strayer Education

Finding dividend stocks is always a good idea if you're thinking for the long term. Just avoid these seven names in particular.

7 F-Rated Dividend Stocks to Avoid

WBA stock has plunged following Amazon's online pharmacy announcement. Walgreen's CFO cautioned on market overreaction.

Walgreens CFO Plays Down Impact of Amazon Online Pharmacy

James Kehoe, Walgreens' chief financial officer, said he doesn't think Amazon's push into the online pharmacy world is cause for concern, Bloomberg reported. Speaking at the Wolfe Healthcare Conference on Thursday (Nov. 19), Kehoe wasn't fussed about the dramatic shock to the stock market once Amazon debuted the service.

Walgreens CFO Unfazed By Amazon's Pharmacy Entry

Deerfield, Illinois-based pharmacy chain Walgreens has launched a revamped customer loyalty program, myWalgreens, which promises its customers new benefits as the company closes down its previous offering, Balance Rewards. In a press release, the company said it aims to provide its customers with the “fastest same-day retail pickup offering available today.

Walgreens Launches New Loyalty Program, Ups Same-Day Service

Walgreens Boots Alliance Inc said on Thursday its customers can now use its mobile app or shop online and pick up health and wellness products at its stores in about 30 minutes.

Walgreens to offer same-day pickup for online shoppers

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens today announced the launch of myWalgreens, a complete reinvention of its customer loyalty program to offer customers extensive new benefits, including the fastest same-day retail pickup offering available today*. Customers can now shop online and on a fully-redesigned mobile app for health and wellness items, and then pick them up in the store, curbside or at the drive-thru in as little as 30 minutes.** Walgreens has the nation's largest health and we

Walgreens Reinvents Nation's Largest Health and Wellbeing-centered Loyalty Program with myWalgreens to Offer Customers Many More Benefits

U.S. officials are seeing "tremendous uptake" of a program that will allow CVS Health and Walgreens to administer Covid vaccines to seniors in facilities.

Trump officials see 'tremendous uptake' of CVS, Walgreens Covid vaccine program for seniors

The market is irrationally selling Walgreens off on the news of Amazon's entry as an online pharmacy. Walgreens is selling off more than CVS, which doesn't make sense given their lack of mail-order pharmacy exposure.

Walgreens: Amazon Driven Panic Makes This The Next 'Target'

CVS Health and Walgreens are touting their ability to administer Covid-19 vaccines once available as Amazon pushes deeper into the pharmacy business.

Here's Something CVS And Walgreens Can Do That Amazon Can't: Give You A Covid-19 Vaccination

Alexion Pharma

Altria

Western Digital

Value investors, get those shopping carts ready.

4 of the Cheapest Stocks to Buy Right Now

A formidable competitor is entering the healthcare arena.

Why CVS, Walgreens, Rite Aid, and Other Pharmacy Stocks Plunged Today

Shares of insurers and prescription coupon firms also tanked after Amazon's announcement.

Amazon's Pharmacy Play Wipes $10 Billion From Walgreens And CVS Market Values

The announcement sent shares of CVS tumbling 8.8 percent Tuesday afternoon, while Rite Aid plummeted 16 percent and Walgreens Boots Alliance was down 8.4 percent.

Amazon Pharmacy announcement sends stocks of drugstore chains tumbling

Boeing

Cisco Systems

Chevron

SPDR Dow Jones Industrial Average ETF

The Dow Jones hit all-time highs since February, marking its fastest bear market recovery in 30 years.

Dow ETF Hits New Highs on Vaccine Optimism: 5 Best Stocks

Drugstore stocks, such as CVS, Walgreens, Goodrx Holdings, and Rite Aid are taking a beating on Tuesday following news from Amazon. The post Drugstore Stocks News: Why CVS, WBA, GDRX and RAD Are Sinking Today appeared first on InvestorPlace.

Drugstore Stocks News: Why CVS, WBA, GDRX and RAD Are Sinking Today

Amazon's foray into the prescription-medicine space deepened on Tuesday after the e-commerce giant launched a digital pharmacy store as a section within its retail website. Now, shoppers can buy their prescription medicines directly from Amazon's website, with the ability to pay with insurance or without. Amazon Prime members will receive discounts on certain medicines and two-day shipping, adding a few more perks to the list of Amazon Prime benefits.

Pharmacy stocks are getting Amazon'd as the consumer giant pushes into online prescriptions — and CVS and Walgreens are tanking

Consumer healthcare stocks are plummeting this morning on news that Amazon has finally launched its integrated pharmacy service. Amazon launches Amazon Pharmacy, a delivery service for prescription medications The news, which could dramatically reshape the healthcare landscape by offering deep discounts on prescription medication and two-day delivery services for Amazon Prime customers, has already taken […]

GoodRx, Walgreens, CVS shares all down on Amazon's Pharmacy news

CVS, Rite Aid and other pharmacy stocks were under pressure on Tuesday morning after Amazon's newest venture was announced.

Walgreens drops 11% to lead drug store stocks lower after Amazon launches pharmacy business

Amazon

Here's what you need to know about Amazon's move to become the prescription drugs king. Amazon has officially launched Amazon Pharmacy, and with it, its hopes of dethroning CVS, Walgreens, and Walmart as the place where most Americans get their prescription drugs.

Watch out CVS and Walgreens, Amazon Pharmacy is here

Shares of drug store chains tumbled Tuesday, after Amazon.com Inc. launched a rival online pharmacy, that provides discounts and free two-day delivery for Prime members. Walgreens Boots Alliance Inc.'s stock plunged 9.8% to pace the Dow Jones Industrial Average's premarket losers.

Walgreens, CVS stocks tumble after Amazon launches rival pharmacy

Kohl's

Walmart

It was once just a catchphrase but more retailers are figuring out ways to cash in on the health and wellness movement driven by Covid and demographics

Walmart, Kohl's And Big Drug Chains Look For Wealth From Health

Walgreens (WBA) reported earnings 30 days ago. What's next for the stock?

Walgreens (WBA) Up 13.5% Since Last Earnings Report: Can It Continue?

Baidu

Incyte

The terms "Nasdaq" and "undervalued" do not go hand-in-hand in the minds of most investors. The high-profile tech and tech-adjacent stocks that make up the index are usually awarded eye-watering valuations as investors have already priced in their anticipated growth for the years and even decades to come.

News for Walgreens Stock (WBA)